Homing of immune cells: Role in homeostasis and intestinal inflammation

Inflammatory Bowel Diseases

Volumn 16, Issue 11, 2010, Pages 1969-1977

  Hart, Ailsa L ^a   Ng, Siew C ^a   Mann, Elizabeth ^a   Al Hassi, Hafid Omar ^a   Bernardo, David ^a   Knight, Stella C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

dendritic cells; homing; inflammatory bowel diseases

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR9; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; NATALIZUMAB; VEDOLIZUMAB;

B LYMPHOCYTE; BACK; BIOLOGICAL THERAPY; CELL HOMING; CELL MIGRATION; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HEALTH; HOME; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFLAMMATORY DISEASE; INTESTINE; JOINT; LIVER; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MICROENVIRONMENT; MOTIVATION; MULTIPLE SCLEROSIS; NONHUMAN; ORGAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REGULATORY T LYMPHOCYTE; REVIEW; SKIN; T LYMPHOCYTE; ULCERATIVE COLITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL MIGRATION INHIBITION; DENDRITIC CELLS; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTEGRIN ALPHA4; INTESTINES; LYMPHOCYTES; MICE; RECEPTORS, CCR;

EID: 78249263839     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21304     Document Type: Review

References (87)

1. von Andrian UH, Mackay CR,. T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000; 343: 1020-1034.
2. Mora JR,. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. Inflamm Bowel Dis. 2008; 14: 275-289.
3. Luster AD, Alon R, von Andrian UH,. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol. 2005; 6: 1182-1190.
4. Butcher EC, Williams M, Youngman K, et al. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999; 72: 209-253.
5. Zabel BA, Agace WW, Campbell JJ, et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 1999; 190: 1241-1256.
6. Nakache M, Berg EL, Streeter PR, et al. The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes. Nature. 1989; 337: 179-181.
7. Wagner N, Lohler J, Kunkel EJ, et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature. 1996; 382: 366-370.
8. Lefrancois L, Parker CM, Olson S, et al. The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med. 1999; 189: 1631-1638.
9. Berlin C, Berg EL, Briskin MJ, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 1993; 74: 185-195.
10. Ghosh S,. Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab. Expert Opin Biol Ther. 2003; 3: 995-1000.
11. Rott LS, Rose JR, Bass D, et al. Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest. 1997; 100: 1204-1208.
12. Rose JR, Williams MB, Rott LS, et al. Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol. 1998; 72: 726-730.
13. Gonzalez JC, Kwok WW, Wald A, et al. Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2. J Infect Dis. 2005; 191: 243-254.
14. Wurbel MA, Malissen M, Guy-Grand D, et al. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T-and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood. 2001; 98: 2626-2632.
15. Svensson M, Marsal J, Ericsson A, et al. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J Clin Invest. 2002; 110: 1113-1121.
16. Johansson-Lindbom B, Svensson M, Wurbel MA, et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003; 198: 963-969.
17. Hosoe N, Miura S, Watanabe C, et al. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am J Physiol Gastrointest Liver Physiol. 2004; 286: G458-G466.
18. Kunkel EJ, Campbell JJ, Haraldsen G, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000; 192: 761-768.
19. Papadakis KA, Prehn J, Nelson V, et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000; 165: 5069-5076.
20. Ericsson A, Kotarsky K, Svensson M, et al. Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors. J Immunol. 2006; 176: 3642-3651.
21. Stenstad H, Svensson M, Cucak H, et al. Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine. Proc Natl Acad Sci U S A. 2007; 104: 10122-10127.
22. Sigmundsdottir H, Pan J, Debes GF, et al. DCs metabolize sunlight-induced vitamin D3 to program T cell attraction to the epidermal chemokine CCL27. Nat Immunol. 2007; 8: 285-293.
23. Pan J, Kunkel EJ, Gosslar U, et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol. 2000; 165: 2943-2949.
24. Kunkel EJ, Campbell DJ, Butcher EC,. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation. 2003; 10: 313-323.
25. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999; 400: 776-780.
26. Campbell JJ, O'Connell DJ, Wurbel MA,. Cutting edge: chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol. 2007; 178: 3358-3362.
27. Mora JR, von Andrian UH,. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin Immunol. 2009; 21: 28-35.
28. Stagg AJ, Kamm MA, Knight SC,. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol. 2002; 32: 1445-1454.
29. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyers patch dendritic cells. Nature. 2003; 424: 88-93.
30. Johansson-Lindbom B, Svensson M, Pabst O, et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med. 2005; 202: 1063-1073.
31. Iwata M, Hirakiyama A, Eshima Y, et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004; 21: 527-538.
32. Mora JR, Iwata M, Eksteen B, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 2006; 314: 1157-1160.
33. Sigmundsdottir H, Butcher EC,. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol. 2008; 9: 981-987.
34. Kang SG, Lim HW, Andrisani OM, et al. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol. 2007; 179: 3724-3733.
35. Denning TL, Wang YC, Patel SR, et al. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol. 2007; 8: 1086-1094.
36. Coombes JL, Maloy KJ,. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol. 2007; 19: 116-126.
37. Jaensson E, Uronen-Hansson H, Pabst O, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med. 2008; 205: 2139-2149.
38. Wendland M, Czeloth N, Mach N, et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Natl Acad Sci U S A. 2007; 104: 6347-6352.
39. Hadeiba H, Sato T, Habtezion A, et al. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol. 2008; 9: 1253-1260.
40. Butler M, Ng CY, van Heel DA, et al. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur J Immunol. 2006; 36: 864-874.
41. Hammerschmidt SI, Ahrendt M, Bode U, et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med. 2008; 205: 2483-2490.
42. Dudda JC, Lembo A, Bachtanian E, et al. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur J Immunol. 2005; 35: 1056-1065.
43. Kapsenberg ML,. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003; 3: 984-993.
44. Edele F, Molenaar R, Gutle D, et al. Cutting edge: instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns. J Immunol. 2008; 181: 3745-3749.
45. Rimoldi M, Chieppa M, Larghi P, et al. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood. 2005; 106: 2818-2826.
46. Iliev ID, Mileti E, Matteoli G, et al. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2009; 2: 340-350.
47. Iliev ID, Spadoni I, Mileti E, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut. 2009; 58: 1481-1489.
48. Worbs T, Bode U, Yan S, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med. 2006; 203: 519-527.
49. Kang SG, Wang C, Matsumoto S, et al. High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation. Gastroenterology. 2009; 137: 1391-1402.
50. Drakes ML, Stiff PJ, Blanchard TG,. Inverse relationship between dendritic cell CCR9 expression and maturation state. Immunology. 2009; 127: 466-476.
51. Coombes JL, Powrie F,. Dendritic cells in intestinal immune regulation. Nat Rev Immunol. 2008; 8: 435-446.
52. Varol C, Vallon-Eberhard A, Elinav E, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 2009; 31: 502-512.
53. Bogunovic M, Ginhoux F, Helft J, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009; 31: 513-525.
54. Rescigno M,. Before they were gut dendritic cells. Immunity. 2009; 31: 454-456.
55. Raki M, Tollefsen S, Molberg O, et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology. 2006; 131: 428-438.
56. Laffont S, Powrie F,. Immunology: dendritic-cell genealogy. Nature. 2009; 462: 732-733.
57. Siewert C, Menning A, Dudda J, et al. Induction of organ-selective CD4+ regulatory T cell homing. Eur J Immunol. 2007; 37: 978-989.
58. Annacker O, Coombes JL, Malmstrom V, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med. 2005; 202: 1051-1061.
59. Coombes JL, Siddiqui KR, Rancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007; 204: 1757-1764.
60. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007; 204: 1775-1785.
61. Benson MJ, Pino-Lagos K, Rosemblatt M, et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007; 204: 1765-1774.
62. Uematsu S, Fujimoto K, Jang MH, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol. 2008; 9: 769-776.
63. Wilson E, Butcher EC,. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med. 2004; 200: 805-809.
64. Kunkel EJ, Kim CH, Lazarus NH, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest. 2003; 111: 1001-1010.
65. Shigematsu T, Specian RD, Wolf RE, et al. MAdCAM mediates lymphocyte-endothelial cell adhesion in a murine model of chronic colitis. Am J Physiol Gastrointest Liver Physiol. 2001; 281: G1309-G1315.
66. Kawachi S, Morise Z, Jennings SR, et al. Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. Inflamm Bowel Dis. 2000; 6: 171-180.
67. Picarella D, Hurlbut P, Rottman J, et al. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol. 1997; 158: 2099-2106.
68. Kato S, Hokari R, Matsuzaki K, et al. Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1. J Pharmacol Exp Ther. 2000; 295: 183-189.
69. Farkas S, Hornung M, Sattler C, et al. Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis. Int J Colorectal Dis. 2006; 21: 71-78.
70. Matsuzaki K, Tsuzuki Y, Matsunaga H, et al. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol. 2005; 140: 22-31.
71. Goto A, Arimura Y, Shinomura Y, et al. Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis. Inflamm Bowel Dis. 2006; 12: 758-765.
72. Podolsky DK, Lobb R, King N, et al. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest. 1993; 92: 372-380.
73. Hesterberg PE, Winsor-Hines D, Briskin MJ, et al. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology. 1996; 111: 1373-1380.
74. Rivera-Nieves J, Ho J, Bamias G, et al. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology. 2006; 131: 1518-1529.
75. Rivera-Nieves J, Olson T, Bamias G, et al. L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. J Immunol. 2005; 174: 2343-2352.
76. Park EJ, Mora JR, Carman CV, et al. Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut. J Clin Invest. 2007; 117: 2526-2538.
77. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999; 45: 856-863.
78. Arihiro S, Ohtani H, Suzuki M, et al. Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohns disease. Pathol Int. 2002; 52: 367-374.
79. Briskin M, Winsor-Hines D, Shyjan A, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol. 1997; 151: 97-110.
80. Hart AL, Kamm MA, Knight SC, et al. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohns disease patients and healthy controls. Clin Exp Immunol. 2004; 135: 137-145.
81. Hart AL, Kamm MA, Knight SC, et al. Prospective evaluation of intestinal homing memory T cells in ulcerative colitis. Inflamm Bowel Dis. 2004; 10: 496-503.
82. Papadakis KA, Prehn J, Moreno ST, et al. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohns disease. Gastroenterology. 2001; 121: 246-254.
83. Eksteen B, Grant AJ, Miles A, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med. 2004; 200: 1511-1517.
84. Targan SR, Feagan BG, Fedorak RN, et al. Natalizumab for the treatment of active Crohns disease: results of the ENCORE Trial. Gastroenterology. 2007; 132: 1672-1683.
85. Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003; 348: 15-23.
86. Feagan BG, Greenberg GR, Wild G, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med. 2005; 352: 2499-2507.
87. Hart AL, Al-Hassi HO, Rigby RJ, et al. Characteristics of interstinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005; 129: 50-65.